Skip to content

Current ratio at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
1.4×-0.1×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
3.2×-2.8×
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
5.7×-1.0×
iRadimed logo
iRadimedIRMD
7.1×-1.7×
Ginkgo Bioworks logo
Ginkgo BioworksDNA
5.2×+0.3×
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
2.7×-0.1×

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×

Where this comes from

Calculated from Rapid Micro Biosystems’s reported figures.

Based on the most recent quarter.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's current ratio?
Rapid Micro Biosystems (RPID) reported current ratio of 2.6× in Q1 2026.
How has Rapid Micro Biosystems's current ratio changed year-over-year?
Rapid Micro Biosystems's current ratio decreased by 44.2% year-over-year, from 4.6× to 2.6×.
What is the long-term trend for Rapid Micro Biosystems's current ratio?
Over 5 years (2020 to 2025), Rapid Micro Biosystems's current ratio has grown at a -3.7% compound annual growth rate (CAGR), from 4× to 3.3×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.